{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:55:07Z","timestamp":1793710507873,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","award":["T34IR8095"],"award-info":[{"award-number":["T34IR8095"]}],"id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY027510"],"award-info":[{"award-number":["R01EY027510"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY026574"],"award-info":[{"award-number":["R01EY026574"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY019869"],"award-info":[{"award-number":["R01EY019869"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY011008"],"award-info":[{"award-number":["R01EY011008"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY029058"],"award-info":[{"award-number":["R01EY029058"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY022589"],"award-info":[{"award-number":["P30EY022589"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY034148"],"award-info":[{"award-number":["R01EY034148"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002806","name":"Carl Zeiss Meditec AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001608","name":"EyeSight Foundation of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005188","name":"Tobacco-Related Disease Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ogla.2025.07.008","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T23:28:16Z","timestamp":1755905296000},"page":"S6-S13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"S","title":["Intraocular Pressure Matters"],"prefix":"10.1016","volume":"8","author":[{"given":"Sasan","family":"Moghimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Girkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-3202","authenticated-orcid":false,"given":"Robert N.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2025.07.008_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1377\/hlthaff.7.1.19","article-title":"The quality of medical evidence: implications for quality of care","volume":"7","author":"Eddy","year":"1988","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ogla.2025.07.008_bib2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib6","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajo.2014.04.003","article-title":"Visual field improvement in the collaborative initial glaucoma treatment study","volume":"158","author":"Musch","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0002-9394(01)01028-5","article-title":"Comparison of glaucoma outcomes in black and white patients within treatment groups","volume":"132","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The AGIS investigators: the Advanced Glaucoma Intervention Study (AGIS): 7: the relationship between control of intraocular pressure and visual field deterioration","volume":"130","author":"Douglas","year":"2000","journal-title":"Am J Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study - baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ophtha.2006.05.075","article-title":"Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study","volume":"114","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archophthalmol.2010.20","article-title":"Delaying treatment of ocular hypertension: the ocular hypertension treatment study","volume":"128","author":"Kass","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib13","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ogla.2025.07.008_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/jamaophthalmol.2021.0341","article-title":"Assessment of cumulative incidence and severity of primary open-angle glaucoma among participants in the ocular hypertension treatment study after 20 years of follow-up","volume":"139","author":"Kass","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ajo.2024.11.017","article-title":"Visual field progression in the Ocular Hypertension Treatment Study","volume":"271","author":"Gordon","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ophtha.2024.01.007","article-title":"Evaluating primary treatment for people with advanced glaucoma: five-year results of the Treatment of Advanced Glaucoma Study","volume":"131","author":"King","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bjophthalmol-2013-303622","article-title":"External validation of the OHTS-EGPS model for predicting the 5-year risk of open-angle glaucoma in ocular hypertensives","volume":"98","author":"Takwoingi","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archopht.1995.01100070092031","article-title":"Risk factors for open-angle glaucoma. The Barbados Eye Study","volume":"113","author":"Leske","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib19","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ophtha.2004.01.025","article-title":"Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study","volume":"111","author":"Varma","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2021.11.018","article-title":"Multilayer macula vessel density and visual field progression in glaucoma","volume":"237","author":"Kamalipour","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2021.6433","article-title":"Association of initial optical coherence tomography angiography vessel density loss with faster visual field loss in glaucoma","volume":"140","author":"Nishida","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib22","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.ophtha.2018.05.006","article-title":"Macular and optic nerve head vessel density and progressive retinal nerve fiber layer loss in glaucoma","volume":"125","author":"Moghimi","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib23","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1167\/iovs.08-3095","article-title":"Interactions between geometry and mechanical properties on the optic nerve head","volume":"50","author":"Sigal","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2025.07.008_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mechrescom.2012.01.007","article-title":"Perspectives on biomechanical growth and remodeling mechanisms in glaucoma","volume":"42","author":"Grytz","year":"2012","journal-title":"Mech Res Commun"},{"key":"10.1016\/j.ogla.2025.07.008_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.exer.2010.09.005","article-title":"A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma","volume":"93","author":"Burgoyne","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ogla.2025.07.008_bib26","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1167\/iovs.16-20000","article-title":"Experimental glaucoma causes optic nerve head neural rim tissue compression: a potentially important mechanism of axon injury","volume":"57","author":"Fortune","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2025.07.008_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.624983","article-title":"Glial cells in glaucoma: friends, foes, and potential therapeutic targets","volume":"12","author":"Garc\u00eda-Berm\u00fadez","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.ogla.2025.07.008_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/bjo.84.3.303","article-title":"Retinal ganglion cell death in experimental glaucoma","volume":"84","author":"Morgan","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archopht.1981.03930010635009","article-title":"Optic nerve damage in human glaucoma II the site of injury and susceptibility to damage","volume":"99","author":"Quigley","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ogla.2025.07.008_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13089","article-title":"Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension","volume":"19","author":"Rocha","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.ogla.2025.07.008_bib32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.molcel.2015.07.027","article-title":"P16INK4a upregulation mediated by SIX6 defines retinal ganglion cell pathogenesis in glaucoma","volume":"59","author":"Skowronska-Krawczyk","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.ogla.2025.07.008_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13737","article-title":"Stress induced aging in mouse eye","volume":"21","author":"Xu","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.ogla.2025.07.008_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109722","article-title":"A new model of axon degeneration in the mouse optic nerve using repeat intraocular pressure challenge","volume":"238","author":"Chrysostomou","year":"2024","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ogla.2025.07.008_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2024.108465","article-title":"Acute ocular hypertension in the living human eye: model description and initial cellular responses to elevated intraocular pressure","volume":"223","author":"Girkin","year":"2024","journal-title":"Vision Res"},{"key":"10.1016\/j.ogla.2025.07.008_bib36","first-page":"1491","article-title":"Regulation of retinal and optic nerve blood flow","volume":"116","author":"Harris","year":"1998","journal-title":"Mech Ophthal Dis"},{"key":"10.1016\/j.ogla.2025.07.008_bib37","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1038\/s41598-018-24520-x","article-title":"Optical coherence tomography angiography vessel density changes after acute intraocular pressure elevation","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ogla.2025.07.008_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ajo.2025.05.010","article-title":"Intraocular pressure monitoring using an implantable sensor detects structural glaucoma progression in the EYEMATE-IO Trial","volume":"277","author":"Micheletti","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archopht.124.2.269","article-title":"Nocturnal rhythms of intraocular pressure","volume":"124","author":"Weinreb","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib40","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ophtha.2007.08.012","article-title":"Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma","volume":"115","author":"Medeiros","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2006.07.060","article-title":"Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial","volume":"114","author":"Bengtsson","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib42","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study","volume":"111","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib43","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ophtha.2007.10.031","article-title":"Intraocular pressure fluctuation: a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study","volume":"115","author":"Caprioli","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/jovr.jovr_35_18","article-title":"Intraocular pressure fluctuation: is it important?","volume":"13","author":"Kim","year":"2018","journal-title":"J Ophthal Vis Res"},{"key":"10.1016\/j.ogla.2025.07.008_bib45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajo.2024.03.028","article-title":"Association of long-term intraocular pressure variability and rate of ganglion complex thinning in patients with glaucoma","volume":"264","author":"Mahmoudinezhad","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib46","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamaophthalmol.2022.4462","article-title":"Association of intraocular pressure with retinal nerve fiber layer thinning in patients with glaucoma","volume":"140","author":"Nishida","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib47","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ophtha.2020.03.029","article-title":"Visual field outcomes from the multicenter, randomized controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)","volume":"127","author":"Wright","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajo.2023.02.008","article-title":"Five-year visual field outcomes of the HORIZON trial","volume":"251","author":"Montesano","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.07.008_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","article-title":"Laser in glaucoma and ocular hypertension (LiGHT) trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension","volume":"130","author":"Gazzard","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.07.008_bib50","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1167\/iovs.11-8639","article-title":"Incorporating risk factors to improve the assessment of rates of glaucomatous progression","volume":"53","author":"Medeiros","year":"2012","journal-title":"Invest Ophth Vis Sci"},{"key":"10.1016\/j.ogla.2025.07.008_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1167\/iovs.66.1.32","article-title":"Relationship between intraocular pressure and the true rate of functional and structural progression in the United Kingdom Glaucoma Treatment Study","volume":"66","author":"Montesano","year":"2025","journal-title":"Invest Ophth Vis Sci"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258941962500153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258941962500153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:20:35Z","timestamp":1772914835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258941962500153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S258941962500153X"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2025.07.008","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraocular Pressure Matters","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2025.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}